As AI chatbots gain adoption in clinical medicine, developing effective frameworks for complex, emerging diseases presents significant challenges. We developed and evaluated six Retrieval-Augmented Generation (RAG) corpus configurations for Long COVID (LC) clinical question answering, ranging from expert-curated sources to large-scale literature databases. Our evaluation employed an LLM-as-a-judge framework across faithfulness, relevance, and comprehensiveness metrics using LongCOVID-CQ, a novel dataset of expert-generated clinical questions. Our RAG corpus configuration combining clinical guidelines with high-quality systematic reviews consistently outperformed both narrow single-guideline approaches and large-scale literature databases. Our findings suggest that for emerging diseases, retrieval grounded in curated secondary reviews provides an optimal balance between narrow consensus documents and unfiltered primary literature, supporting clinical decision-making while avoiding information overload and oversimplified guidance. We propose Guide-RAG, a chatbot system and accompanying evaluation framework that integrates both curated expert knowledge and comprehensive literature databases to effectively answer LC clinical questions.

Process mining has emerged as a powerful analytical technique for understanding complex healthcare workflows. However, its application faces significant barriers, including technical complexity, a lack of standardized approaches, and limited access to practical training resources. We introduce HealthProcessAI, a GenAI framework designed to simplify process mining applications in healthcare and epidemiology by providing a comprehensive wrapper around existing Python (PM4PY) and R (bupaR) libraries. To address unfamiliarity and improve accessibility, the framework integrates multiple Large Language Models (LLMs) for automated process map interpretation and report generation, helping translate technical analyses into outputs that diverse users can readily understand. We validated the framework using sepsis progression data as a proof-of-concept example and compared the outputs of five state-of-the-art LLM models through the OpenRouter platform. To test its functionality, the framework successfully processed sepsis data across four proof-of-concept scenarios, demonstrating robust technical performance and its capability to generate reports through automated LLM analysis. LLM evaluation using five independent LLMs as automated evaluators revealed distinct model strengths: Claude Sonnet-4 and Gemini 2.5-Pro achieved the highest consistency scores (3.79/4.0 and 3.65/4.0) when evaluated by automated LLM assessors. By integrating multiple Large Language Models (LLMs) for automated interpretation and report generation, the framework addresses widespread unfamiliarity with process mining outputs, making them more accessible to clinicians, data scientists, and researchers. This structured analytics and AI-driven interpretation combination represents a novel methodological advance in translating complex process mining results into potentially actionable insights for healthcare applications.

Despite the diversity of brain data acquired and advanced AI-based algorithms to analyze them, brain features are rarely used in clinics for diagnosis and prognosis. Here we argue that the field continues to rely on cohort comparisons to seek biomarkers, despite the well-established degeneracy of brain features. Using a thought experiment, we show that more data and more powerful algorithms will not be sufficient to identify biomarkers of brain diseases. We argue that instead of comparing patient versus healthy controls using single data type, we should use multimodal (e.g. brain activity, neurotransmitters, neuromodulators, brain imaging) and longitudinal brain data to guide the grouping before defining multidimensional biomarkers for brain diseases.

It might sound like a scenario from the most far-fetched of science fiction novels. But scientists have revealed the 32 terrifyingly real ways that AI systems could go rogue. Researchers warn that sufficiently advanced AI might start to develop'behavioural abnormalities' which mirror human psychopathologies. From relatively harmless'Existential Anxiety' to the potentially catastrophic 'Übermenschal Ascendancy', any of these machine mental illnesses could lead to AI escaping human control. As AI systems become more complex and gain the ability to reflect on themselves, scientists are concerned that their errors may go far beyond simple computer bugs.

Background: Cirrhosis is a progressive liver disease with high mortality and frequent complications, notably acute kidney injury (AKI), which occurs in up to 50% of hospitalized patients and worsens outcomes. AKI stems from complex hemodynamic, inflammatory, and metabolic changes, making early detection essential. Many predictive tools lack accuracy, interpretability, and alignment with intensive care unit (ICU) workflows. This study developed an interpretable machine learning model for early AKI prediction in critically ill patients with cirrhosis. Methods: We conducted a retrospective analysis of the MIMIC-IV v2.2 database, identifying 1240 adult ICU patients with cirrhosis and excluding those with ICU stays under 48 hours or missing key data. Laboratory and physiological variables from the first 48 hours were extracted. The pipeline included preprocessing, missingness filtering, LASSO feature selection, and SMOTE class balancing. Six algorithms-LightGBM, CatBoost, XGBoost, logistic regression, naive Bayes, and neural networks-were trained and evaluated using AUROC, accuracy, F1-score, sensitivity, specificity, and predictive values. Results: LightGBM achieved the best performance (AUROC 0.808, 95% CI 0.741-0.856; accuracy 0.704; NPV 0.911). Key predictors included prolonged partial thromboplastin time, absence of outside-facility 20G placement, low pH, and altered pO2, consistent with known cirrhosis-AKI mechanisms and suggesting actionable targets. Conclusion: The LightGBM-based model enables accurate early AKI risk stratification in ICU patients with cirrhosis using routine clinical variables. Its high negative predictive value supports safe de-escalation for low-risk patients, and interpretability fosters clinician trust and targeted prevention. External validation and integration into electronic health record systems are warranted.

Traditional echocardiographic parameters such as ejection fraction (EF) and global longitudinal strain (GLS) have limitations in the early detection of cardiac dysfunction. EF often remains normal despite underlying pathology, and GLS is influenced by load conditions and vendor variability. There is a growing need for reproducible, interpretable, and operator-independent parameters that capture subtle and global cardiac functional alterations. We introduce the Acoustic Index, a novel AI-derived echocardiographic parameter designed to quantify cardiac dysfunction from standard ultrasound views. The model combines Extended Dynamic Mode Decomposition (EDMD) based on Koopman operator theory with a hybrid neural network that incorporates clinical metadata. Spatiotemporal dynamics are extracted from echocardiographic sequences to identify coherent motion patterns. These are weighted via attention mechanisms and fused with clinical data using manifold learning, resulting in a continuous score from 0 (low risk) to 1 (high risk). In a prospective cohort of 736 patients, encompassing various cardiac pathologies and normal controls, the Acoustic Index achieved an area under the curve (AUC) of 0.89 in an independent test set. Cross-validation across five folds confirmed the robustness of the model, showing that both sensitivity and specificity exceeded 0.8 when evaluated on independent data. Threshold-based analysis demonstrated stable trade-offs between sensitivity and specificity, with optimal discrimination near this threshold. The Acoustic Index represents a physics-informed, interpretable AI biomarker for cardiac function. It shows promise as a scalable, vendor-independent tool for early detection, triage, and longitudinal monitoring. Future directions include external validation, longitudinal studies, and adaptation to disease-specific classifiers.

Medical diagnosis prediction plays a critical role in disease detection and personalized healthcare. While machine learning (ML) models have been widely adopted for this task, their reliance on supervised training limits their ability to generalize to unseen cases, particularly given the high cost of acquiring large, labeled datasets. Large language models (LLMs) have shown promise in leveraging language abilities and biomedical knowledge for diagnosis prediction. However, they often suffer from hallucinations, lack structured medical reasoning, and produce useless outputs. T o address these challenges, we propose KERAP, a knowledge graph (KG)-enhanced reasoning approach that improves LLM-based diagnosis prediction through a multi-agent architecture. Our framework consists of a linkage agent for attribute mapping, a retrieval agent for structured knowledge extraction, and a prediction agent that iteratively refines diagnosis predictions. Experimental results demonstrate that KERAP enhances diagnostic reliability efficiently, offering a scalable and interpretable solution for zero-shot medical diagnosis prediction.

Aaron Rodgers praised the performance of his teammate Davante Adams in the New York Jets' 32-25 win over the Jacksonville Jaguars. New York Jets owner Woody Johnson is back in the spotlight this week after a bombshell report accused the former ambassador of passing on a trade for Cleveland Browns star receiver Jerry Juedy because of his Madden NFL rating. A report from The Athletic published Thursday morning painted a picture of dysfunction for the organization, which missed out on the playoffs for the 14th straight year, the longest active streak in the NFL. At the heart of that dysfunction, according to the report, is Johnson. An example detailed in the report was the Jets' decision to kill a trade with the Denver Broncos involving former first round pick Jerry Jeudy. Sources told The Athletic that despite the negotiations of former general manager Joe Douglas and the interest of his counterpart, George Paton, the deal was called off because Johnson was influenced by the player's rating in Madden NFL.

It might seem a little convenient coming from a group of highly educated scientists. But researchers now say that geeks make better romantic partners than any muscle-bound meathead. In a new study, scientists from Oakland University claim that intelligent men have better relationship outcomes and are less likely to be abusive towards their partners. And, in good news for nerds, the researchers even claim that smarter men are less likely to suffer from erectile dysfunction. The scientists tested the intelligence of men in heterosexual relationships and then surveyed them for a range of different positive or negative relationship traits.

SARS-CoV-2, the highly contagious pathogen responsible for the COVID-19 pandemic, has persistent effects that begin four weeks after initial infection and last for an undetermined duration. These chronic effects are more harmful than acute ones. This review explores the long-term impact of the virus on various human organs, including the pulmonary, cardiovascular, neurological, reproductive, gastrointestinal, musculoskeletal, endocrine, and lymphoid systems, particularly in older adults. Regarding diagnosis, RT-PCR is the gold standard for detecting COVID-19, though it requires specialized equipment, skilled personnel, and considerable time to produce results. To address these limitations, artificial intelligence in imaging and microfluidics technologies offers promising alternatives for diagnosing COVID-19 efficiently. Pharmacological and non-pharmacological strategies are effective in mitigating the persistent impacts of COVID-19. These strategies enhance immunity in post-COVID-19 patients by reducing cytokine release syndrome, improving T cell response, and increasing the circulation of activated natural killer and CD8 T cells in blood and tissues. This, in turn, alleviates symptoms such as fever, nausea, fatigue, muscle weakness, and pain. Vaccines, including inactivated viral, live attenuated viral, protein subunit, viral vectored, mRNA, DNA, and nanoparticle vaccines, significantly reduce the adverse long-term effects of the virus. However, no vaccine has been reported to provide lifetime protection against COVID-19. Consequently, protective measures such as physical distancing, mask usage, and hand hygiene remain essential strategies. This review offers a comprehensive understanding of the persistent effects of COVID-19 on individuals of varying ages, along with insights into diagnosis, treatment, vaccination, and future preventative measures against the spread of SARS-CoV-2.